Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.Transplantation|March 30, 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter StudyPaolo De Simone, Renato Romagnoli, Francesco Tandoi, et al.Hepatology (Baltimore, Md.)|April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionNancy Reau, Paul Y Kwo, Susan Rhee, et al.Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.Journal of Viral Hepatitis|November 14, 2018
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven Flamm, David Mutimer, Armen Asatryan, et al.Hepatology (Baltimore, Md.)|October 17, 2015
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humansChristabel Kelly, Leo Swadling, Stefania Capone, et al.The Lancet. Infectious Diseases|February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialMichael Manns, Didier Samuel, Edward J Gane, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.Pageof 5